These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 31032490)

  • 1. Fentanyl overdose in a female with the
    El-Deeb M; Adams P; Schneider A; Salcedo-Arellano MJ; Tassone F; Hagerman R
    J Mol Genet (Isleworth); 2018 Nov; 1(1):. PubMed ID: 31032490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fragile X- associated Neuropsychiatric Disorders: A Case Report.
    Tan MM; Dy JB; Salcedo-Arellano MJ; Tassone F; Hagerman RJ
    Future Neurol; 2019 May; 14(2):. PubMed ID: 32089651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prodromal Markers of Upper Limb Deficits in
    O'Keefe JA; Bang D; Robertson EE; Biskis A; Ouyang B; Liu Y; Pal G; Berry-Kravis E; Hall DA
    Mov Disord Clin Pract; 2020 Oct; 7(7):810-819. PubMed ID: 33043077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Advances Leading to Treatment Implications for Fragile X Premutation Carriers.
    Polussa J; Schneider A; Hagerman R
    Brain Disord Ther; 2014; 3():. PubMed ID: 25436181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placebo Response in Fragile X-associated Tremor/Ataxia Syndrome.
    Hill EJ; Goetz CG; Stebbins GT; Hagerman R; Ouyang B; Hall DA
    Mov Disord Clin Pract; 2020 Apr; 7(3):298-302. PubMed ID: 32258228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinsonism Versus Concomitant Parkinson's Disease in Fragile X-Associated Tremor/Ataxia Syndrome.
    Salcedo-Arellano MJ; Wolf-Ochoa MW; Hong T; Amina S; Tassone F; Lechpammer M; Hagerman R; Martínez-Cerdeño V
    Mov Disord Clin Pract; 2020 May; 7(4):413-418. PubMed ID: 32373658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The primary cognitive deficit among males with fragile X-associated tremor/ataxia syndrome (FXTAS) is a dysexecutive syndrome.
    Brega AG; Goodrich G; Bennett RE; Hessl D; Engle K; Leehey MA; Bounds LS; Paulich MJ; Hagerman RJ; Hagerman PJ; Cogswell JB; Tassone F; Reynolds A; Kooken R; Kenny M; Grigsby J
    J Clin Exp Neuropsychol; 2008 Nov; 30(8):853-69. PubMed ID: 18608667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ataxia as the Major Manifestation of Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS): Case Series.
    Salcedo-Arellano MJ; Cabal-Herrera AM; Tassanakijpanich N; McLennan YA; Hagerman RJ
    Biomedicines; 2020 May; 8(5):. PubMed ID: 32466255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fragile X associated neuropsychiatric disorders in a male without FXTAS.
    Cabal-Herrera AM; Saldarriaga-Gil W; Salcedo-Arellano MJ; Hagerman RJ
    Intractable Rare Dis Res; 2020 May; 9(2):113-118. PubMed ID: 32494560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of AQP4 functional variants and its association with fragile X-associated tremor/ataxia syndrome.
    Elias-Mas A; Potrony M; Bague J; Cutler DJ; Alvarez-Mora MI; Torres T; Barcos T; Puig-Butille JA; Rubio M; Madrigal I; Puig S; Allen EG; Rodriguez-Revenga L
    Front Aging Neurosci; 2022; 14():1073258. PubMed ID: 36688175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Women with Fragile X-associated Tremor/Ataxia Syndrome.
    Schneider A; Summers S; Tassone F; Seritan A; Hessl D; Hagerman P; Hagerman R
    Mov Disord Clin Pract; 2020 Nov; 7(8):910-919. PubMed ID: 33163562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultra-high-field 7-Tesla magnetic resonance imaging in fragile X tremor/ataxia syndrome (FXTAS).
    Lakhani DA; Agarwal AK; Middlebrooks EH
    Neuroradiol J; 2024 Apr; ():19714009241247464. PubMed ID: 38644331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of Comorbid Conditions in Women Who Carry an
    Allen EG; Charen K; Hipp HS; Shubeck L; Amin A; He W; Hunter JE; Shelly KE; Sherman SL
    Front Psychiatry; 2021; 12():715922. PubMed ID: 34658954
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessment of Molecular Measures in Non-FXTAS Male Premutation Carriers.
    Al Olaby RR; Tang HT; Durbin-Johnson B; Schneider A; Hessl D; Rivera SM; Tassone F
    Front Genet; 2018; 9():302. PubMed ID: 30186307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Longitudinal Study of Executive Function in Daily Life in Male Fragile X Premutation Carriers and Association with FXTAS Conversion.
    Hessl D; Rojas KM; Ferrer E; Espinal G; Famula J; Schneider A; Elagerman R; Tassone F; Rivera SM
    medRxiv; 2023 Sep; ():. PubMed ID: 37693384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ages of Onset of Mood and Anxiety Disorders in Fragile X Premutation Carriers.
    Seritan AL; Bourgeois JA; Schneider A; Mu Y; Hagerman RJ; Nguyen DV
    Curr Psychiatry Rev; 2013 Feb; 9(1):65-71. PubMed ID: 25844075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case Report: Coexistence of Alzheimer-Type Neuropathology in Fragile X-Associated Tremor Ataxia Syndrome.
    Salcedo-Arellano MJ; Sanchez D; Wang JY; McLennan YA; Clark CJ; Juarez P; Schneider A; Tassone F; Hagerman RJ; Martínez-Cerdeño V
    Front Neurosci; 2021; 15():720253. PubMed ID: 34602969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychiatric Manifestations in Early to Middle Stages of Fragile X-Associated Tremor-Ataxia Syndrome (FXTAS).
    Chi MH; Bourgeois JA; Santos E; Kim K; Ponzini MD; Mendoza G; Schneider A; Hessl D; Tassone F; Hagerman RJ
    J Neuropsychiatry Clin Neurosci; 2024 Aug; ():appineuropsych20230215. PubMed ID: 39113493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Gaps in Understanding the Molecular Basis of FXTAS.
    Hagerman PJ
    Tremor Other Hyperkinet Mov (N Y); 2012; 2():. PubMed ID: 23440729
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.